Do the financial arrangements for joint working need to be included in the Executive Summary?

  • 20

    Joint working between one or more pharmaceutical companies and the NHS and others is acceptable provided that this is carried out in a manner compatible with the Code. Joint working must always benefit patients.

    A formal written agreement must be in place and an executive summary of the joint working agreement must be made publicly available before arrangements are implemented.

    Transfers of value made by companies in connection with joint working must be publicly disclosed.

    Supplementary information

Yes. A Joint Working Executive Summary should contain a summary of the main points covered in the Joint Working agreement. See Clause 20.